Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Previously at the epicenter of the U.S. opioid crisis, Purdue Pharma is looking to reenter the public lexicon as a new public benefit company. After a prior bankruptcy settlement was nixed by the ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...

Currently, many new drugs come on stream in some EU states much quicker than others. [ Pharma firms ‘disappointed and concerned’ by lack of State support for campaign against EU reformsOpens ...

Preclinical research is crucial for the development of any novel drug. It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...

I don't think big mergers are likely in the imminent future. How do you view the overall pharma business scenario? The branded generics business grows slower than the commodity business, but it lasts ...

My wife and I would both be dead, but for what many derisively call “Big Pharma.” My wife has a rare, genetic form of stage four lung cancer for which there is no cure. Her lungs are filled ...

Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and personalized experiences. The Fast Company Executive Board is a private ...

Modern society’s relationship with mental health has evolved in recent decades. Once taboo, conditions such as depression and bipolar disorder are now openly discussed by high-profile figures ...

Companies developing 505(b)(2), NDA, ANDA, branded or generic prescription drug products are encouraged to explore LGM Pharma’s expanded manufacturing capabilities by visiting LGMPharma.com or ...